Moreover, GLK overexpression also occurs in patients with other autoimmune diseases, such as Graves’ disease, Sjogren’s syndrome, and neuromyelitis optica, as well as in patients with cancer recurrence/metastasis [63,64,65,66]. Here, MAP4K3 is linked to cancer.